BioSpace News Archive

Recent Medicare data demonstrates Northwestern as national leader in value-based healthcare

CSols has been recognized as a Top Workplace in the small business category (< 100 employees) according to a national survey sponsored locally by The News Journal (Wilmington, Delaware).

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced it has been named one of the global biopharmaceutical industry’s top employers in Science and Science Careers’ 2019 Top Employers Survey

Medline and HOTB Software Solutions today announced an exclusive partnership to assist ambulatory surgery centers (ASC) in managing and navigating accreditation compliance processes using a new Surgical Center Toolbox.

The Association for Frontotemporal Degeneration (AFTD) held its annual Hope Rising Benefit on Wednesday night, raising more than $2 million in support of the organization’s mission.

Advocates for patients with Lyme disease were on Capitol Hill Tuesday to raise awareness about the growing threat to public health of the tick-borne disease, including the launch of a new national organization dedicated to increasing federal funding for better diagnosis and treatment options.

Pharmacy technicians now have options in all states for national certification. National Healthcareer Association’s Exam for the Certification of Pharmacy Technicians (ExCPT®) is now accepted in all states that require certification as well as all states that either expand the number of permitted pharmacy technicians or the scope of pharmacy technician practice based on certification.

Today, Augmedix announced that it has received $19 million in Series B funding that includes investments from Redmile Group, McKesson Ventures, DCM Ventures, Wanxiang Healthcare Investments and others.

ShiraTronics, Inc., a private medical device company, today announced it has completed a Series A financing of $33 million.

Amgen (NASDAQ:AMGN) today announced that it will report its third quarter financial results on Tuesday, Oct. 29, 2019, after the close of the U.S. financial markets.